The preliminary study on the relationship between HPVassociated cervical cancer and p53 codon 72 polymorphism in sichuan province

Chinese-German Journal of Clinical Oncology

Volumn 2, Issue 3, 2003, Pages 160-162

  Xi, Mingrong ^a   He, Yuedong ^a   Yang, Xiaoyun ^a   Hou, Minmin ^a   Cao, Zeyi ^a  

^a WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

Author keywords

Heterozygote; Homozygote; HPV associated cervical cancer; P53 codon 72; Polymorphism

Indexed keywords

EID: 33744801820     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/BF02842290     Document Type: Article

References (5)

1. Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirusassociated cancer. Nature, 1998, 393: 229-234.
2. Rosenthal AN, Ryan A, Al-Jehani RM, et aL p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet, 1998, 352: 871-872.
3. Thomas M, Massimi P, Jenkins J, et al. HPV-18 E6 mediated inbibition of p53DNA binding activity is independent of E6 induced degradation. Oncogene, 1995, 10: 261-268.
4. Milner J, Medcalf EA. Cotranslation of activated mutant p53 with wild-type drives the wild-type p53 protein into the mutant conformation. Cell, 1991, 65: 765-774.
5. Yu H, Chen JK, Feng S, et al. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell, 1994, 76: 933-945.